Microglia-mediated Neuroinflammation Is Implicated in Many Environmental Illnesses. What is it?




Neuroinflammation is a term that describes the activation of immune cells in the central nervous system (CNS) in response to various stimuli, such as infections, injuries, toxins, or neurodegenerative diseases [1]. Microglia are the resident immune cells of the CNS and are the main mediators of neuroinflammation. They act as the first line of defense in the brain by phagocytosing harmful pathogens and cellular debris, as well as producing inflammatory cytokines and chemokines that recruit other immune cells and modulate neuronal activity [2].

Microglia-mediated neuroinflammation can have both beneficial and detrimental effects on the CNS. On one hand, it can help to clear infections, repair tissue damage, and promote neurogenesis and synaptic plasticity [3]. On the other hand, it can also cause neuronal death, synaptic loss, oxidative stress, and blood-brain barrier disruption [4]. The balance between these effects depends on the type, intensity, duration, and location of the inflammatory stimulus, as well as the phenotype and function of microglia [5].

Microglia-mediated neuroinflammation has been implicated in various neurological disorders, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. (See note.) In these disorders, microglia may become chronically activated and contribute to the pathological process by releasing pro-inflammatory mediators, enhancing oxidative stress, and promoting neurotoxicity [6]. Therefore, understanding the role of microglia in neuroinflammation and neurodegeneration may provide new insights into the pathogenesis and therapy of these diseases [7]. 


(Note - It has also been implicated in several 'environmental illnesses.)



Search the Blog! #microglia   #neuroinflammation

References:

[1] Streit WJ, Mrak RE, Griffin WS. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1:14.

[2] Muzio L, Viotti A, Martino G. Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy. Front Neurosci. 2021;15:742065.

[3] Ginhoux F, Lim S, Hoeffel G, Low D, Huber T. Origin and differentiation of microglia. Front Cell Neurosci. 2013;7:45.

[4] Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57-69.

[5] Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987-991.

[6] Heneka MT, Carson MJ, El Khoury J et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388-405.

[7] Perry VH, Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol. 2014;10(4):217-224.

Comments